(Q36340661)

13 August 2017

1 reference

title

Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview (English)

1 reference

13 August 2017

0 references

Carrasco JL

1

1 reference

13 August 2017

Sandner C

series ordinal

2

1 reference

13 August 2017

publication date

1 December 2005

1 reference

International Journal of Clinical Practice

13 August 2017

published in

1 reference

13 August 2017

volume

59

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

1428-1434

1 reference

A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00681.X

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00681.X

Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00681.X

Fluoxetine in elderly patients: is there cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00681.X

Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00681.X

10.1111/J.1368-5031.2005.00681.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference